NovoCure Ltd (NASDAQ:NVCR) currently has a daily average trading volume of 909.75K but it saw 873347 shares traded in last market. With a market cap of 2.16B USD, the company’s current market price of $19.37 came rising about 0.99 while comparing to the previous closing price of $19.18. In past 52 weeks, the stock remained buoying in the range of price level as high as $34.13 and as low as $14.17.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Evercore ISI which upgraded the stock as “Outperform” in its note to investors issued on December 02, 2024, recommending a price target of between $18 and $30 for it. H.C. Wainwright upgraded its recommendation for the stock as a “Buy” from “Neutral” on October 16, 2024 while assigning a price target range of $24-$30. JP Morgan issued its recommendations for the stock as it resumed the price target for the stock is $15.
Over the week, NVCR’s stock price is moving 6.43% up while it is 5.79% when we observe its performance for the past one month. Year-to-date it is -35.00% down and over the past year, the stock is showing a downside performance of -13.18%.
Currently, NovoCure Ltd’s total number of outstanding shares is 111.48M with 9.70% of that held by the insiders while 87.79% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -32.86% and return on equity (ROE) at -45.52%. Stock’s beta reads 0.74. Stock has a price to book (P/B) ratio of 5.97 while price to sale or P/S ratio amounts to 3.47. Its return on asset (ROA) is -13.85% on average.
